Patel Sanj K bought KNSA
June 1, 2026 · Form 4 insider transaction
Patel Sanj K bought 900,000 shares of Kiniksa Pharmaceuticals International, plc, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
900,000
Price
N/A
Total value
N/A
InsiderPatel Sanj K
RoleOfficer, Director
SecurityClass A Ordinary Share
Transaction codeC: Conversion of a derivative
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after951,794
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party.